FDA 483 - Community Fertility Specialty Care - January 11, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Community Fertility Specialty Care in Indianapolis, IN, revealed significant deficiencies in donor eligibility determination and communicable disease testing for oocyte donors. The firm failed to test donors for relevant communicable diseases like West Nile Virus and Hepatitis B, and did not maintain proper documentation for donor eligibility. Additionally, the facility's procedures were inadequate to ensure compliance with required donor screening tests.
ID · ad04e738-2cad-4753-a080-fd81a3a9ee90